Collaboration Agreements in the Biotechnology Industry

1,217 Contracts & Agreements

Browse by Company

4D Molecular Therapeutics Inc (3 contracts)
89bio, Inc. (1)
ACADIA PHARMACEUTICALS INC (1)
ACCELERON PHARMA INC (4)
Acorda Therapeutics (2)
Acumen Pharmaceuticals, Inc. (2)
Adagio Therapeutics, Inc. (2)
Adaptimmune Therapeutics PLC (5)
Adhera Therapeutics, Inc. (1)
ADiTx Therapeutics, Inc. (1)
ADURO BIOTECH, INC. (2)
Advaxis, Inc. (4)
Adverum Biotechnologies, Inc. (4)
AGENUS INC (1)
AGIOS PHARMACEUTICALS INC (1)
Aimmune Therapeutics, Inc. (3)
AKCEA THERAPEUTICS, INC. (5)
Akebia Therapeutics, Inc. (3)
Alector, Inc. (4)
Alkermes plc. (5)
Allogene Therapeutics, Inc. (6)
Allovir, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (27)
ALPINE IMMUNE SCIENCES, INC. (1)
Amgen Inc. (16)
AMICUS THERAPEUTICS, INC. (10)
AmpliPhi Biosciences Corp (3)
ANAPTYSBIO INC (5)
ANAVEX LIFE SCIENCES CORP. (2)
Anixa Biosciences Inc (6)
Aptevo Therapeutics Inc. (6)
Aptinyx Inc. (1)
AQUINOX PHARMACEUTICALS, INC (2)
Aravive, Inc. (1)
ARCA biopharma, Inc. (12)
Arcellx, Inc. (1)
Arcturus Therapeutics Holdings Inc. (3)
Arcus Biosciences, Inc. (4)
Arcutis Biotherapeutics, Inc. (1)
ARENA PHARMACEUTICALS INC (1)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (4)
Arsanis, Inc. (1)
Artiva Biotherapeutics, Inc. (3)
ASSEMBLY BIOSCIENCES, INC. (3)
Atara Biotherapeutics, Inc. (4)
Athenex, Inc. (1)
ATHERSYS, INC (5)
Atreca, Inc. (1)
aTYR PHARMA INC (1)
AVEO PHARMACEUTICALS INC (4)
Avidity Biosciences, Inc. (2)
BeiGene, Ltd. (6)
BELLICUM PHARMACEUTICALS, INC (1)
BICYCLE THERAPEUTICS Ltd (8)
BioAtla, Inc. (3)
BIOCEPT INC (7)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOMARIN PHARMACEUTICAL INC (1)
BioXcel Therapeutics, Inc. (1)
Blue Water Vaccines Inc. (2)
bluebird bio, Inc. (4)
Blueprint Medicines Corp (11)
BridgeBio Pharma, Inc. (2)
C4 Therapeutics, Inc. (3)
CALADRIUS BIOSCIENCES, INC. (1)
Calithera Biosciences, Inc. (1)
CAPRICOR THERAPEUTICS, INC. (1)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
Caribou Biosciences, Inc. (12)
Castle Creek Biosciences, Inc. (3)
CATALYST BIOSCIENCES, INC. (5)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (4)
Cellular Biomedicine Group, Inc. (1)
Century Therapeutics, Inc. (7)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (2)
ChemoCentryx, Inc. (2)
CHIMERIX INC (1)
Cibus Global, Ltd. (1)
Cidara Therapeutics, Inc. (1)
Clovis Oncology, Inc. (3)
CM Life Sciences III Inc. (1)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (1)
Consonance-HFW Acquisition Corp. (1)
CONSTELLATION PHARMACEUTICALS INC (2)
Corbus Pharmaceuticals Holdings, Inc. (1)
CRISPR Therapeutics AG (6)
CTI BIOPHARMA CORP (2)
Cue Biopharma, Inc. (14)
Cullinan Oncology, LLC (3)
CURIS INC (7)
Cyclacel Pharmaceuticals, Inc. (4)
CytoDyn Inc. (2)
Cytokinetics, Incorporated (12)
CytomX Therapeutics, Inc. (18)
DBV Technologies S.A. (1)
Decibel Therapeutics, Inc. (1)
Denali Therapeutics Inc. (3)
DiaMedica Therapeutics Inc. (1)
Dicerna Pharmaceuticals Inc (7)
Diffusion Pharmaceuticals Inc. (1)
DYADIC INTERNATIONAL INC (2)
Dynamics Special Purpose Corp. (3)
DYNAVAX TECHNOLOGIES CORP (2)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (3)
Editas Medicine, Inc. (4)
Eiger BioPharmaceuticals, Inc. (3)
Elevation Oncology, Inc. (3)
Entrada Therapeutics, Inc. (4)
ENZON PHARMACEUTICALS, INC. (8)
Epizyme, Inc. (12)
Equillium, Inc. (6)
Esperion Therapeutics, Inc. (8)
Evelo Biosciences, Inc. (1)
Exelixis (46)
EXICURE, INC. (2)
FATE THERAPEUTICS INC (4)
Fibrocell Science, Inc. (3)
FIBROGEN INC (3)
FIVE PRIME THERAPEUTICS INC (21)
Flex Pharma, Inc. (1)
Foghorn Therapeutics Inc. (1)
Forma Therapeutics Holdings, Inc., (1)
Forty Seven, Inc. (1)
Frequency Therapeutics, Inc. (2)
Fusion Pharmaceuticals Inc. (5)
GALECTIN THERAPEUTICS INC (2)
Generation Bio Co. (1)
GENETHERA INC (1)
GENOCEA BIOSCIENCES, INC. (1)
Genprex, Inc. (2)
Gilead Sciences (3)
Global Blood Therapeutics, Inc. (1)
GLYCOMIMETICS INC (1)
Gossamer Bio, Inc. (1)
Gritstone Oncology, Inc. (2)
GTX INC (8)
Harpoon Therapeutics, Inc. (6)
Hillstream BioPharma Inc. (1)
Homology Medicines, Inc. (6)
HOOKIPA Pharma Inc. (2)
HUMANIGEN, INC (1)
iBio, Inc. (2)
IDEAYA Biosciences, Inc. (13)
IDERA PHARMACEUTICALS, INC. (6)
IGM Biosciences, Inc. (1)
Immix Biopharma, Inc. (1)
IMMUNOGEN INC (8)
IMMUNOMEDICS INC (3)
Incyte (7)
INOVIO PHARMACEUTICALS, INC. (7)
Intellia Therapeutics, Inc. (3)
INTREXON CORP (19)
Intrinsic Medicine, Inc. (1)
IO Biotech, Inc. (2)
IONIS PHARMACEUTICALS INC (29)
IRONWOOD PHARMACEUTICALS INC (4)
iTeos Therapeutics, Inc. (2)
Janux Therapeutics, Inc. (1)
Keros Therapeutics, Inc. (1)
Kezar Life Sciences, Inc. (2)
Kindred Biosciences, Inc. (1)
Kiromic Biopharma, Inc. (2)
Kronos Bio, Inc. (1)
Kura Oncology, Inc. (1)
Kymera Therapeutics, Inc. (4)
LEAP THERAPEUTICS, INC. (3)
LEXICON PHARMACEUTICALS, INC. (8)
LianBio (6)
Ligand Pharmaceuticals Incorporated (2)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (3)
Locust Walk Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (1)
Lyell Immunopharma, Inc. (3)
MACROGENICS INC (5)
MADRIGAL PHARMACEUTICALS, INC. (3)
Magenta Therapeutics, Inc. (8)
MANNKIND CORP (3)
MeiraGTx Holdings plc (2)
Mersana Therapeutics, Inc. (17)
Merus N.V. (2)
MIRAGEN THERAPEUTICS, INC. (11)
Mirati Therapeutics, Inc. (4)
Moderna, Inc. (2)
Molecular Templates, Inc. (5)
Momenta Pharmaceuticals, Inc. (6)
Monte Rosa Therapeutics, Inc. (2)
Morphic Holding, Inc. (9)
MYMETICS CORP (2)
Myriad Genetics, Inc. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (2)
NEUROCRINE BIOSCIENCES INC (9)
NEUROTROPE BIOSCIENCE, INC. (1)
NEWLINK GENETICS CORP (7)
NextCure, Inc. (2)
Nkarta, Inc. (5)
NOVAVAX INC (5)
NTN BUZZTIME INC (1)
Nuo Therapeutics, Inc. (1)
Nurix Therapeutics, Inc. (10)
Olema Pharmaceuticals, Inc. (5)
Olivia Ventures, Inc. (2)
Omega Therapeutics, Inc. (2)
OncoCyte Corp (1)
ONCOSEC MEDICAL Inc (1)
Opko Health, Inc. (2)
ORAGENICS INC (8)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (2)
Oric Pharmaceuticals, Inc. (2)
Ovid Therapeutics Inc. (3)
Pasithea Therapeutics Corp. (4)
Passage BIO, Inc. (14)
PDL BIOPHARMA, INC. (1)
PharmaCyte Biotech, Inc. (1)
PIERIS PHARMACEUTICALS, INC. (16)
PORTOLA PHARMACEUTICALS INC (3)
Poseida Therapeutics, Inc. (5)
Praxis Precision Medicines, Inc. (1)
PRECISION BIOSCIENCES INC (4)
Prometheus Biosciences, Inc. (1)
Protagonist Therapeutics, Inc (7)
PROTEOSTASIS THERAPEUTICS, INC. (6)
Prothena Corp plc (1)
PTC THERAPEUTICS, INC. (5)
PUMA BIOTECHNOLOGY, INC. (1)
Pyxis Oncology, Inc. (1)
Rallybio Corp (1)
RAPT Therapeutics, Inc. (4)
RECURSION PHARMACEUTICALS, INC. (4)
Regeneron Pharmaceuticals (19)
REGENXBIO Inc. (1)
Regulus Therapeutics Inc. (4)
Relay Therapeutics, Inc. (4)
RenovaCare, Inc. (1)
Repare Therapeutics Inc. (10)
Replimune Group, Inc. (2)
Retrophin, Inc. (2)
REXAHN PHARMACEUTICALS, INC. (5)
Rezolute, Inc. (2)
Rich Pharmaceuticals, Inc. (2)
RIGEL PHARMACEUTICALS INC (8)
Sage Therapeutics, Inc. (1)
SANGAMO THERAPEUTICS, INC (12)
Sarepta Therapeutics, Inc. (15)
Savara Inc (3)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (19)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (1)
Shattuck Labs, Inc. (3)
Sigilon Therapeutics, Inc. (2)
Silverback Therapeutics, Inc. (2)
Solid Biosciences Inc. (1)
SOLIGENIX, INC. (3)
Sorrento Therapeutics, Inc. (1)
SpringWorks Therapeutics, Inc. (3)
SQZ Biotechnologies Co (2)
SUNESIS PHARMACEUTICALS INC (3)
SUTRO BIOPHARMA, INC. (3)
Syndax Pharmaceuticals Inc (5)
SYNLOGIC, INC. (2)
Synthetic Biologics, Inc. (5)
Syros Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (3)
Taysha Gene Therapies, Inc. (2)
TG THERAPEUTICS, INC. (1)
Tonix Pharmaceuticals Holding Corp. (1)
Tracon Pharmaceuticals, Inc. (1)
Translate Bio, Inc. (3)
TScan Therapeutics, Inc. (2)
Turning Point Therapeutics, Inc. (1)
Ultragenyx Pharmaceutical Inc. (18)
uniQure N.V. (3)
United Therapeutics Corp (1)
Unum Therapeutics Inc. (1)
VACCINEX, INC. (1)
Vaccitech plc (1)
VBI Vaccines Inc (5)
Verastem, Inc. (2)
Verve Therapeutics, Inc. (1)
VICAL INC (2)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (17)
VistaGen Therapeutics, Inc. (3)
Voyager Therapeutics, Inc. (4)
Werewolf Therapeutics, Inc. (1)
WINDTREE THERAPEUTICS INC (6)
Xencor Inc (8)
Xenetic Biosciences, Inc. (1)
Xenon Pharmaceuticals Inc. (2)
XOMA Corp (8)
YIELD10 BIOSCIENCE, INC. (1)
Zai Lab Ltd (7)
ZIOPHARM ONCOLOGY INC (1)
Zymeworks Inc. (3)

Recent Contracts

First Amendment to Option, License and Collaboration Agreement, dated December 19, 2024, by and between the Company and Gilead Sciences, Inc (ASSEMBLY BIOSCIENCES, INC., Filed With SEC on December 19, 2024)
Amendment 3 to Development Collaboration Agreement (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on December 2, 2024)
Fourth Amendment to Collaboration, License and Option Agreement, dated September 16, 2024, by and between Curis, Inc. and Aurigene Discovery Technologies Limite (CURIS INC, Filed With SEC on November 14, 2024)
Third Amendment to Collaboration, License and Option Agreement, dated June 4, 2020, by and between Curis, Inc. and Aurigene Discovery Technologies Limited (CURIS INC, Filed With SEC on November 14, 2024)
Second Amended and Restated Research, Collaboration & License Agreement, dated July 31, 2024, by and between the Registrant and the Trustees of the University of Pennsylvania (Passage BIO, Inc., Filed With SEC on November 13, 2024)
Research, Collaboration & License Agreement, dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Passage BIO, Inc., Filed With SEC on November 13, 2024)
Exclusive License and Collaboration Agreement, effective as of September 9, 2024, with Factor Bioscience Limited (NTN BUZZTIME INC, Filed With SEC on November 12, 2024)
Research Collaboration and License Agreement, dated September 13, 2024 between Korro Bio, Inc. and Novo Nordisk A/S (Frequency Therapeutics, Inc., Filed With SEC on November 12, 2024)
Amendment No.4 to Collaboration and Option Agreement by and between the Registrant and Ono Pharmaceutical Co., Ltd, dated August 28, 2024 (FATE THERAPEUTICS INC, Filed With SEC on November 12, 2024)
Third Amendment to the Collaboration and License Agreement, dated August 14, 2024, by and among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Poseida Therapeutics, Inc., Filed With SEC on November 7, 2024)
Amendments to Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd., dated October 29, 2018 (RIGEL PHARMACEUTICALS INC, Filed With SEC on November 7, 2024)
Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd., dated September 3, 2024 (RIGEL PHARMACEUTICALS INC, Filed With SEC on November 7, 2024)
Fourth Amendment to the Collaboration and License Agreement by and between the Company and Incyte Corporation, Inc., dated July 24, 2024 (MACROGENICS INC, Filed With SEC on November 5, 2024)
Amendment No. 3 entered into as of August 1, 2024 to the Master Collaboration Agreement dated as of April 8, 2019 by and between the Registrant and Regeneron Pharmaceuticals, Inc (ALNYLAM PHARMACEUTICALS, INC., Filed With SEC on October 31, 2024)
Market Development and Collaboration Agreement (ADiTx Therapeutics, Inc., Filed With SEC on September 23, 2024)
Amendment No. 4 to the Research Collaboration Agreement, dated May 2, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Nkarta, Inc., Filed With SEC on August 13, 2024)
Amendment No. 3 to the Research Collaboration Agreement, dated April 3, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Nkarta, Inc., Filed With SEC on August 13, 2024)
Amendment No. 1 to Collaboration and License Agreement by and between the Company and Everest Medicines II (HK) Limited, dated as of July 2, 2024 (Kezar Life Sciences, Inc., Filed With SEC on August 13, 2024)
Collaboration and License Agreement dated May 3, 2024 by and among GB002, Inc., Gossamer Bio 002 Ltd. and Gossamer Bio, Inc. on the one hand and CHIESI Farmaceutici S.p.A and... (Gossamer Bio, Inc., Filed With SEC on August 12, 2024)
First Amended and Restated Collaboration Agreement, dated April 2, 2024, by and between Adimab, LLC and Leap Therapeutics, Inc (LEAP THERAPEUTICS, INC., Filed With SEC on August 12, 2024)
FNAIT Collaboration Agreement, dated April 9, 2024, by and between Momenta Pharmaceuticals, Inc. and Rallybio IPA, LLC (Rallybio Corp, Filed With SEC on August 8, 2024)
Amendment No. 4 to the Option, License and Collaboration Agreement between Arcus Biosciences, Inc. and Gilead Sciences, Inc., dated May 10, 2024 (Arcus Biosciences, Inc., Filed With SEC on August 8, 2024)
Amendment No.1 to the Collaboration and License Agreement effective as of June 28, 2024 by and between CytomX Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc (CytomX Therapeutics, Inc., Filed With SEC on August 8, 2024)
Amendment No. 1 to Amended and Restated Collaboration and License Agreement, dated May 17, 2024, by and between Allogene Therapeutics, Inc. and Notch Therapeutics (Canada) Inc (Allogene Therapeutics, Inc., Filed With SEC on August 7, 2024)
Addendum to Collaboration and License Agreement between argenx BV and Zai Auto Immune (Hong Kong) Limited dated June 30, 2024 (Zai Lab Ltd, Filed With SEC on August 6, 2024)
First Amendment to Collaboration Agreement, by and between Registrant and Neurocrine Biosciences, Inc., dated April 3, 2024 (Voyager Therapeutics, Inc., Filed With SEC on August 6, 2024)
Collaboration Agreement, dated as of April 4, 2024, by and between the Company and BiBo Biopharma Engineering Co., Ltd (89bio, Inc., Filed With SEC on August 5, 2024)
Collaboration and License Agreement, by and between the Registrant and Xyphos Biosciences, Inc. dated April 30, 2024 (Poseida Therapeutics, Inc., Filed With SEC on August 5, 2024)
Fifth Amendment to License and Collaboration Agreement between Alkermes Pharma Ireland Limited and Biogen International GmbH (as successor to Biogen Swiss Manufacturing GmbH),... (Alkermes plc., Filed With SEC on July 24, 2024)
Amendment No. 1, dated June 26, 2023, to Collaboration Agreement, dated July 19, 2021, by and between Proteomedix AG and New Horizon Health Limited (Blue Water Vaccines Inc., Filed With SEC on June 5, 2024)
Collaboration Agreement, dated July 19, 2021, by and between Proteomedix AG and New Horizon Health Limited (Blue Water Vaccines Inc., Filed With SEC on June 5, 2024)
Second Amendment to the Collaboration and License Agreement, dated February 7, 2024, by and among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Poseida Therapeutics, Inc., Filed With SEC on May 14, 2024)
First Amendment to the Collaboration and License Agreement by and between the Company and Gilead Sciences, Inc., dated (MACROGENICS INC, Filed With SEC on May 9, 2024)
Amendment Number Two to Collaboration and License Agreement, dated March 29, 2024, by and between Arcturus Therapeutics, Inc. and Seqirus Inc (Arcturus Therapeutics Holdings Inc., Filed With SEC on May 8, 2024)
Amendment No. 2 to Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Company and Novartis Institutes for BioMedical Research, Inc., dated March... (Olema Pharmaceuticals, Inc., Filed With SEC on May 8, 2024)
Letter Agreement Amending the 2021 Collaboration and License Agreement between the Registrant and Glaxo Wellcome UK Ltd. dated March 11, 2024 (Alector, Inc., Filed With SEC on May 8, 2024)
Collaboration, Option and License Agreement, dated as of March 5, 2024, by and between Merus N.V. and Gilead Sciences, Inc (Merus N.V., Filed With SEC on May 8, 2024)
Side Letters to Master Collaboration Agreement, dated as of March 20, 2018, between Prothena Biosciences Limited and Celgene Switzerland LLC (Prothena Corp plc, Filed With SEC on May 8, 2024)
Amendment No. 4 to the Collaboration and License Agreement, dated as of March 28, 2024, by and between CytomX Therapeutics, Inc. and Amgen, Inc (CytomX Therapeutics, Inc., Filed With SEC on May 8, 2024)
Fifth Amendment to Collaboration and License Agreement by and between the registrant and Bristol-Myers Squibb Company, dated March 14, 2024 (Repare Therapeutics Inc., Filed With SEC on May 7, 2024)